Publications Digest

MTRC shares the most relevant and impactful publications in the field of market access and HEOR for medical technologies in Europe through its Publications Digest. In a recent publication, Klein et al. evaluated the use of real-world evidence (RWE) by HTA agencies in Europe for assessing the cost-effectiveness of high-risk medical devices. In total, 25 HTA reports using RWE data were reviewed. Authors offered a critical review of the use of RWE in these reports and provided recommendations for improvement.

MTRC shares the most relevant and impactful publications in the field of market access and HEOR for medical technologies in Europe through its Publications Digest. In a recent publication, Mantovani et al. reviewed the current regulatory and reimbursement approaches adopted for digital therapeutics (DTx) and in-vitro diagnostics (IVDs) in the US, Europe, and Australia. In Europe, authors offer an overview of reimbursement pathways in France, Germany and the United Kingdom for digital and in-vitro diagnostic technologies.

MTRC shares the most relevant and impactful publications in the field of market access and HEOR for medical technologies in Europe through its Publications Digest. In a recent publication, Ibargoyen-Roteta et al. summarized the main initiatives in relation to Early Dialogue/Scientific Advice/Early Advice given by international HTA bodies to manufacturers of medical technologies. In relation to medical technologies, the authors reviewed early dialogue frameworks of NICE (UK), Health Technology Wales and HAS (France).

MTRC shares the most relevant and impactful publications in the field of market access and HEOR for medical technologies in Europe through its Publications Digest. In a recent publication, Boriani et al. evaluated the status of the implementation of remote monitoring of cardiac implantable electrical devices. Among other topics, the study provides a useful overview of the reimbursement situation with remote monitoring of cardiac implants in Europe.

MTRC shares the most relevant and impactful publications in the field of market access and HEOR for medical technologies in Europe through its Publications Digest. In a recent publication, Ferrante et al. reviewed methodological approaches from seven HTA organizations, which perform assessments of diagnostic tests and compared approaches with non-diagnostic test HTAs. With the exception of dealing with test accuracy data, approaches were largely based on general approaches to HTA with few test-specific modifications. Elucidation of test claims and attitude to direct and indirect evidence were the areas where authors identified the biggest dissimilarities in approach.

MTRC shares the most relevant and impactful publications in the field of market access and HEOR for medical technologies in Europe through its Publications Digest. In a recent publication, Trippoli et al. examined the sufficiency of DRG tariffs for medical procedures and devices in Italy. The analysis included 24 class III or implantable devices. Authors discovered a large variability in the ratios between device price and DRG associated with its use. This ratio ranged from a minimum of about 3% in the case of the Hyalobarrier gel for post-surgical adhesion to a maximum of 132% in the case of the Neovasc Reducer, a device indicated in the narrowed coronary sinus.

MTRC shares the most relevant and impactful publications in the field of market access and HEOR for medical technologies in Europe through its Publications Digest. In a recent publication, Conrads-Frank et al. performed a critical review of decision-analytic modeling studies to inform early HTA for high-risk medical devices. The study presented a summary of methodological approaches, and made a number of recommendations about technical aspects of health economic analysis for medical devices.